Antiphospholipid Antibody Syndrome Completed Phase Trials for Rofecoxib (DB00533)

IndicationStatusPhase
DBCOND0029330 (Antiphospholipid Antibody Syndrome)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01762891CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and AcetaminophenTreatment